Cargando…
Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms
Terpenes are active constituents of many pharmaceutical dosage forms with natural products origin. One of the challenges in developing dosage forms with herbal origin is their standardization as pharmaceutical products. GC-Mass is the most decisive and reliable technique to fulfill the requirements...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447878/ https://www.ncbi.nlm.nih.gov/pubmed/31011339 |
_version_ | 1783408589234241536 |
---|---|
author | Esfahanizadeh, Marjan Ayatollahi, Seyed Abdolmajid Goodarzi, Ali Bayat, Mitra Ata, Athar Kobarfard, Farzad |
author_facet | Esfahanizadeh, Marjan Ayatollahi, Seyed Abdolmajid Goodarzi, Ali Bayat, Mitra Ata, Athar Kobarfard, Farzad |
author_sort | Esfahanizadeh, Marjan |
collection | PubMed |
description | Terpenes are active constituents of many pharmaceutical dosage forms with natural products origin. One of the challenges in developing dosage forms with herbal origin is their standardization as pharmaceutical products. GC-Mass is the most decisive and reliable technique to fulfill the requirements in this regard. In the present study, a reliable, rapid, and accurate method was developed for determination of 7 monoterpenoids in two selected pharmaceutical dosage forms (rowatinex and rowachol soft gelatin capsules) by gas chromatography-mass spectrometry triple quadrupole selected ion monitoring GC/MS-TQ-SIM. The method was validated for various parameters such as precision, linearity, accuracy, solution stability, limit of detection, and quantification. The average recovery of terpens was in the range of 91.6-105.7%. The method was proved to be repeatable with RSD in the range of 0.28-11.18 for all of the concentration levels. The developed method is simple, rapid, and sensitive and was applied for determination of alpha pinene, camphene, beta pinene, cineol, fenchone, borneol, trans-anethol and menthol in a few batches of rowachol and rowatinex capsules purchased from local drug stores. |
format | Online Article Text |
id | pubmed-6447878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-64478782019-04-22 Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms Esfahanizadeh, Marjan Ayatollahi, Seyed Abdolmajid Goodarzi, Ali Bayat, Mitra Ata, Athar Kobarfard, Farzad Iran J Pharm Res Original Article Terpenes are active constituents of many pharmaceutical dosage forms with natural products origin. One of the challenges in developing dosage forms with herbal origin is their standardization as pharmaceutical products. GC-Mass is the most decisive and reliable technique to fulfill the requirements in this regard. In the present study, a reliable, rapid, and accurate method was developed for determination of 7 monoterpenoids in two selected pharmaceutical dosage forms (rowatinex and rowachol soft gelatin capsules) by gas chromatography-mass spectrometry triple quadrupole selected ion monitoring GC/MS-TQ-SIM. The method was validated for various parameters such as precision, linearity, accuracy, solution stability, limit of detection, and quantification. The average recovery of terpens was in the range of 91.6-105.7%. The method was proved to be repeatable with RSD in the range of 0.28-11.18 for all of the concentration levels. The developed method is simple, rapid, and sensitive and was applied for determination of alpha pinene, camphene, beta pinene, cineol, fenchone, borneol, trans-anethol and menthol in a few batches of rowachol and rowatinex capsules purchased from local drug stores. Shaheed Beheshti University of Medical Sciences 2018 /pmc/articles/PMC6447878/ /pubmed/31011339 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Esfahanizadeh, Marjan Ayatollahi, Seyed Abdolmajid Goodarzi, Ali Bayat, Mitra Ata, Athar Kobarfard, Farzad Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms |
title | Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms |
title_full | Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms |
title_fullStr | Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms |
title_full_unstemmed | Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms |
title_short | Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms |
title_sort | development and validation of a gc/ms method for simultaneous determination of 7 monoterpens in two commercial pharmaceutical dosage forms |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447878/ https://www.ncbi.nlm.nih.gov/pubmed/31011339 |
work_keys_str_mv | AT esfahanizadehmarjan developmentandvalidationofagcmsmethodforsimultaneousdeterminationof7monoterpensintwocommercialpharmaceuticaldosageforms AT ayatollahiseyedabdolmajid developmentandvalidationofagcmsmethodforsimultaneousdeterminationof7monoterpensintwocommercialpharmaceuticaldosageforms AT goodarziali developmentandvalidationofagcmsmethodforsimultaneousdeterminationof7monoterpensintwocommercialpharmaceuticaldosageforms AT bayatmitra developmentandvalidationofagcmsmethodforsimultaneousdeterminationof7monoterpensintwocommercialpharmaceuticaldosageforms AT ataathar developmentandvalidationofagcmsmethodforsimultaneousdeterminationof7monoterpensintwocommercialpharmaceuticaldosageforms AT kobarfardfarzad developmentandvalidationofagcmsmethodforsimultaneousdeterminationof7monoterpensintwocommercialpharmaceuticaldosageforms |